# Minocycline Treatment in Retinitis Pigmentosa

> **NCT04068207** · PHASE2 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 35 (actual)

## Conditions studied

- Retinitis Pigmentosa
- Inherited Retinal Dystrophy
- Retina Disorder

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT04068207
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-25
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-12-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04068207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04068207, "Minocycline Treatment in Retinitis Pigmentosa". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04068207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*